In episode 1, neurologist Catherine Lomen-Hoerth, MD, PhD, is joined by Timothy Miller, MD, PhD, to discuss pivotal long-term data showing tofersen's meaningful impact in patients with SOD1 ALS.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights